USA – Johnson & Johnson has announced the termination of its collaboration and license agreements with Bavarian Nordic to develop potential vaccines against hepatitis B and human papillomaviruses (HPV). However,…
Read MoreJ&J terminates vaccine partnership with Bavarian Nordic
